SCHEMBL5712995

SCHEMBL5712995

Cc1cc(C(=O)N[C@H]2CC(=O)c3ccccc3N(CC(=O)O)C2=O)cc(C)c1O

nearest known ligand 0.48

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PYGL P06737 2/20 0.44
CCKBR P32239 5/20 0.42
ACE P12821 4/20 0.41
MME P08473 3/20 0.41
CCKAR P32238 2/20 0.41
HTR1A P08908 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8520674 0.87 CCKBR (0.42) PYGLCCKBRCCKARHTR1A
SCHEMBL5712951 0.87 CCKBR (0.42) PYGLCCKBRCCKARHTR1A
SCHEMBL7446421 0.85 CASP1 (0.39) PYGLCCKBR
SCHEMBL645168 0.78 XIAP (0.46)
SCHEMBL7446425 0.77 CASP1 (0.32) PYGLHTR1A
SCHEMBL5712978 0.74 CASP1 (0.46) PYGLCCKBRCCKAR
SCHEMBL8521265 0.74 CASP1 (0.46) PYGLCCKBRCCKAR
SCHEMBL644932 0.71 XIAP (0.45) PYGLACEMME
SCHEMBL647728 0.69 XIAP (0.42)
SCHEMBL5712998 0.69 ACE (0.46) ACEMME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0942925-B1 INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME VERTEX PHARMA (US) 2006-11-22 EP disclosed
EP-1466921-A1 Inhibitors of interleukin-1 beta converting enzyme Vertex Pharmaceuticals Incorporated (US) 2004-10-13 EP disclosed
US-6350741-B1 1-BENZAZEPINE DERIVATIVES; ANTIINFLAMMATORY, ANTIARTHRITIC AGENTS; BONE AND AUTOIMMUNE DISORDER TREATMENT VERTEX PHARMACEUTICAL, INC. 2002-02-26 US disclosed
EP-0942925-A2 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME Vertex Pharmaceuticals Incorporated (US) 1999-09-22 EP disclosed
WO-1998024804-A2 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME VERTEX PHARMACEUTICALS INCORPORATED (US) 1998-06-11 WO disclosed